{"timestamp": 1771609059.15099, "value": {"ticker": "ABOS", "company_name": "Acumen Pharmaceuticals, Inc.", "short_name": "Acumen Pharmaceuticals, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 159308112, "float_shares": 35161056, "shares_outstanding": 60573425, "short_ratio": 0.76, "short_percent_of_float": 0.02, "shares_short": 900167, "shares_short_prior": 553811, "insider_percent_held": 0.07463, "institution_percent_held": 0.64634, "total_cash": 126609000, "total_debt": 30836000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 33.095, "current_ratio": 6.019, "book_value": 1.538, "price_to_book": 1.7100132, "operating_cashflow": -123657000, "free_cashflow": -78959504, "price": 2.63, "52w_high": 3.05, "52w_low": 0.855, "avg_volume": 579120, "avg_volume_10d": 410570, "full_time_employees": 61, "audit_risk": 7, "overall_risk": 9}}